The first Post-COVID Syndrome Phase II clinical trial has begun recruiting patients.

BALDWIN PARK, Calif., May 25, 2023 /PRNewswire/ — StemCyte announced it has officially begun recruiting patients under a US Food and Drug Administration (FDA) approved Phase IIa human clinical trial in the United States. This is the world’s first Phase II trial using umbilical cord blood…